Australia To Identify High-Risk Companies Ahead Of First Pharmacovigilance Inspections
Executive Summary
As Australia moves ahead with introducing UK-style pharmacovigilance inspections, it is calling on drug sponsors to complete a risk assessment survey to help it prioritize its work. Non-responsive companies will be assigned the highest risk score under this exercise.